{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:13:35Z","timestamp":1785251615873,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T00:00:00Z","timestamp":1712620800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.tcm.2024.04.001","type":"journal-article","created":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T06:59:31Z","timestamp":1712732371000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Thromboembolic risk and oral anticoagulation in subclinical atrial fibrillation"],"prefix":"10.1016","volume":"35","author":[{"given":"Felix K.","family":"Wegner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3735-8503","authenticated-orcid":false,"given":"Lars","family":"Eckardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.tcm.2024.04.001_bib0001","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.tcm.2024.04.001_bib0002","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study","volume":"129","author":"Chugh","year":"2014","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.tcm.2024.04.001_bib0003","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/europace\/euaa065","volume":"22","author":"Nielsen","year":"2020","journal-title":"Europace"},{"issue":"1","key":"10.1016\/j.tcm.2024.04.001_bib0004","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/europace\/euac062","article-title":"Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET\/EHRA consensus conference","volume":"25","author":"Schnabel","year":"2023","journal-title":"Europace"},{"issue":"1","key":"10.1016\/j.tcm.2024.04.001_bib0005","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"83","author":"Joglar","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.tcm.2024.04.001_bib0006","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jacep.2022.09.011","article-title":"Clinical validation of 5 direct-to-consumer wearable smart devices to detect atrial fibrillation: BASEL wearable study","volume":"9","author":"Mannhart","year":"2023","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.tcm.2024.04.001_bib0007","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejim.2019.11.018","article-title":"Prospective blinded evaluation of the smartphone-based AliveCor Kardia ECG monitor for atrial fibrillation detection: the PEAK-AF study","volume":"73","author":"Wegner","year":"2020","journal-title":"Eur J Intern Med"},{"issue":"5","key":"10.1016\/j.tcm.2024.04.001_bib0008","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1161\/STROKEAHA.111.676189","article-title":"Occult atrial fibrillation in cryptogenic stroke: detection by 7-day electrocardiogram versus implantable cardiac monitors","volume":"44","author":"Ritter","year":"2013","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.tcm.2024.04.001_bib0009","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1161\/STROKEAHA.113.003788","article-title":"Supraventricular premature beats and short atrial runs predict atrial fibrillation in continuously monitored patients with cryptogenic stroke","volume":"45","author":"Kochh\u00e4user","year":"2014","journal-title":"Stroke"},{"issue":"14","key":"10.1016\/j.tcm.2024.04.001_bib0010","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1161\/CIRCULATIONAHA.117.028845","article-title":"Subclinical atrial fibrillation in older patients","volume":"136","author":"Healey","year":"2017","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.tcm.2024.04.001_bib0011","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1105575","article-title":"Subclinical atrial fibrillation and the risk of stroke","volume":"366","author":"Healey","year":"2012","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.tcm.2024.04.001_bib0012","first-page":"179","article-title":"Predisposing factors for atrial fibrillation in the elderly","volume":"14","author":"Wasmer","year":"2017","journal-title":"J Geriatr Cardiol"},{"issue":"20","key":"10.1016\/j.tcm.2024.04.001_bib0013","doi-asserted-by":"crossref","first-page":"e623","DOI":"10.1161\/CIR.0000000000000568","article-title":"Atrial fibrillation burden: moving beyond atrial fibrillation as a binary entity: a scientific statement from the American Heart Association","volume":"137","author":"Chen","year":"2018","journal-title":"Circulation"},{"issue":"8631","key":"10.1016\/j.tcm.2024.04.001_bib0014","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0140-6736(89)91200-2","article-title":"Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study","volume":"1","author":"Petersen","year":"1989","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.tcm.2024.04.001_bib0015","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1253\/circj.CJ-14-0144","article-title":"Validation of CHA\u2082DS\u2082-VASc and HAS-BLED scores in Japanese patients with nonvalvular atrial fibrillation: an analysis of the J-RHYTHM Registry","volume":"78","author":"Okumura","year":"2014","journal-title":"Circ J"},{"issue":"22","key":"10.1016\/j.tcm.2024.04.001_bib0016","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1093\/eurheartj\/ehi489","article-title":"The Euro Heart Survey on atrial fibrillation: a picture and a thousand words","volume":"26","author":"Wyse","year":"2005","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.tcm.2024.04.001_bib0017","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.tcm.2024.04.001_bib0018","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/eurheartj\/ehr488","article-title":"Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study","volume":"33","author":"Friberg","year":"2012","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.tcm.2024.04.001_bib0019","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1212\/WNL.0b013e318287281b","article-title":"CHADS\u2082, CHA\u2082S\u2082DS\u2082-VASc, and long-term stroke outcome in patients without atrial fibrillation","volume":"80","author":"Ntaios","year":"2013","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.tcm.2024.04.001_bib0020","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.tcm.2024.04.001_bib0021","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.tcm.2024.04.001_bib0022","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.tcm.2024.04.001_bib0023","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.tcm.2024.04.001_bib0024","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad166","article-title":"The influence of atrial high-rate episodes on stroke and cardiovascular death: an update","volume":"25","author":"Toennis","year":"2023","journal-title":"Europace"},{"issue":"16","key":"10.1016\/j.tcm.2024.04.001_bib0025","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1161\/CIRCULATIONAHA.115.020252","article-title":"Clinical implications of brief device-detected atrial tachyarrhythmias in a cardiac rhythm management device population: results from the registry of atrial tachycardia and atrial fibrillation episodes","volume":"134","author":"Swiryn","year":"2016","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.tcm.2024.04.001_bib0026","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/eurheartj\/ehx042","article-title":"Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT","volume":"38","author":"van Gelder","year":"2017","journal-title":"Eur Heart J"},{"issue":"20","key":"10.1016\/j.tcm.2024.04.001_bib0027","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1901183","article-title":"Large-scale assessment of a smartwatch to identify atrial fibrillation","volume":"381","author":"Perez","year":"2019","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.tcm.2024.04.001_bib0028","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1016\/j.jacc.2019.08.019","article-title":"Mobile photoplethysmographic technology to detect atrial fibrillation","volume":"74","author":"Guo","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"10310","key":"10.1016\/j.tcm.2024.04.001_bib0029","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/S0140-6736(21)01698-6","article-title":"Implantable loop recorder detection of atrial fibrillation to prevent stroke (The LOOP Study): a randomised controlled trial","volume":"398","author":"Svendsen","year":"2021","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.tcm.2024.04.001_bib0030","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1056\/NEJMoa2303062","article-title":"Anticoagulation with edoxaban in patients with atrial high-rate episodes","volume":"389","author":"Kirchhof","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2024.04.001_bib0031","article-title":"Anticoagulation with edoxaban in patients with long atrial high-rate episodes \u226524 h","author":"Becher","year":"2023","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.tcm.2024.04.001_bib0032","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa2310234","article-title":"Apixaban for stroke prevention in subclinical atrial fibrillation","volume":"390","author":"Healey","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2024.04.001_bib0033","article-title":"Direct oral anticoagulants for stroke prevention in patients with device-detected atrial fibrillation: a study-level meta-analysis of the NOAH-AFNET 6 and ARTESiA trials","author":"McIntyre","year":"2023","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.tcm.2024.04.001_bib0034","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/bcp.14961","article-title":"Number needed to treat for net effect of anticoagulation in atrial fibrillation: real-world vs. clinical-trial evidence","volume":"88","author":"Ding","year":"2022","journal-title":"Br J Clin Pharmacol"},{"issue":"20","key":"10.1016\/j.tcm.2024.04.001_bib0035","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/eurheartj\/ehw007","article-title":"The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis","volume":"37","author":"Ganesan","year":"2016","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.tcm.2024.04.001_bib0036","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1093\/europace\/eux163","volume":"19","author":"Gorenek","year":"2017","journal-title":"Europace"},{"issue":"7","key":"10.1016\/j.tcm.2024.04.001_bib0037","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.amjcard.2016.12.007","article-title":"Comparison of HAS-BLED and HAS-BED versus CHADS2 and CHA2DS2VASC stroke and bleeding scores in patients with atrial fibrillation","volume":"119","author":"Poli","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.tcm.2024.04.001_bib0038","article-title":"Use of direct oral anticoagulants in patients on chronic hemodialysis: contemporary appraisal on the role for patients with atrial fibrillation","author":"Niehues","year":"2023","journal-title":"Trend Cardiovasc Med"},{"issue":"10","key":"10.1016\/j.tcm.2024.04.001_bib0039","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/clc.23257","article-title":"Risk of ischemic stroke and utility of CHA2 DS2 -VASc score in women and men with atrial fibrillation","volume":"42","author":"Tomasdottir","year":"2019","journal-title":"Clin Cardiol"},{"issue":"1","key":"10.1016\/j.tcm.2024.04.001_bib0040","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2300235","article-title":"Apixaban versus aspirin for embolic stroke of undetermined source","volume":"3","author":"Geisler","year":"2024","journal-title":"NEJM Evid"},{"issue":"46","key":"10.1016\/j.tcm.2024.04.001_bib0041","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1093\/eurheartj\/ehz782","article-title":"Cabins, castles, and constant hearts: rhythm control therapy in patients with atrial fibrillation","volume":"40","author":"Willems","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2024.04.001_bib0042","series-title":"OCEANIC-AF study stopped early due to lack of efficacy","author":"Bayer","year":"2023"},{"issue":"14","key":"10.1016\/j.tcm.2024.04.001_bib0043","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2024.04.001_bib0044","article-title":"Benefits of early rhythm control of atrial fibrillation","author":"Eckardt","year":"2023","journal-title":"Trend Cardiovasc Med"},{"issue":"40","key":"10.1016\/j.tcm.2024.04.001_bib0045","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1093\/eurheartj\/ehac471","article-title":"Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: the EAST-AFNET 4 trial","volume":"43","author":"Eckardt","year":"2022","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/j.tcm.2024.04.001_bib0046","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1007\/s00392-022-02012-3","article-title":"Machine learning in the detection and management of atrial fibrillation","volume":"111","author":"Wegner","year":"2022","journal-title":"Clin Res Cardiol"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105017382400032X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105017382400032X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:35:09Z","timestamp":1736469309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105017382400032X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S105017382400032X"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2024.04.001","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thromboembolic risk and oral anticoagulation in subclinical atrial fibrillation","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2024.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}